1267-1276
Original Paper
Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas
Davut Pehlivan, Esra Gunduz, Mehmet Gunduz, Hitoshi Nagatsuka and Levent Bekir Beder, et al.
1277-1287
Original Paper
Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989–2007
Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim and Yong-Man Kim, et al.
1289-1295
Original Paper
Radical systematic mediastinal lymphadenectomy versus mediastinal lymph node sampling in patients with clinical stage IA and pathological stage T1 non-small cell lung cancer
Kai Ma, Dong Chang, Baoliang He, Min Gong and Feng Tian, et al.
1297-1301
Original Paper
Differences in presentation characteristics of renal cell carcinoma in the last 25 years: a single center experience
Dionisios Mitropoulos, Andreas Petrolekas, Ioannis Anastasiou, Ioannis Adamakis and Aspasia Kyroudi-Voulgari, et al.
1303-1310
Original Paper
Oral versus intravenous ibandronic acid: a comparison of treatment options for metastatic bone disease
Kyriaki Mystakidou, Evangelia Stathopoulou, Efi Parpa, Vassilios Kouloulias and Evangelia Kouskouni, et al.
1311-1318
Original Paper
Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study
Volker Arndt, Christa Stegmaier, Hartwig Ziegler and Hermann Brenner
1319-1323
Original Paper
Open AccessClinical identification of colorectal cancer patients benefiting from adjuvant uracil–tegafur (UFT): a randomized controlled trial
Masashi Fujii, Tadatoshi Takayama and Mitsugu Kochi
1325-1335
Original Paper
A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma
Kimberly B. Higginbotham, Richard Lozano, Thomas Brown, Yehuda Z. Patt and Takashi Arima, et al.
1337-1345
Original Paper
MZ3 can induce G2/M-phase arrest and apoptosis in human leukemia cells
Liang Fang, Li Shen, Yanfen Fang, Yongzhou Hu and Qiaojun He, et al.
1347-1354
Original Paper
Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment
Ke-da Yu, Gen-hong Di, Jiong Wu, Jin-song Lu and Kun-wei Shen, et al.
1355-1361
Original Paper
The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma
Wei Li, Wei Wang, Mani Si, Linfei Han and Qinglei Gao, et al.
1363-1369
Original Paper
Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma
Yasuo Awakura, Eijiro Nakamura, Takeshi Takahashi, Hirokazu Kotani and Yoshiki Mikami, et al.
1371-1376
Original Paper
A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer
Hidefumi Sasaki, Katsuhiro Okuda, Minoru Takada, Masaaki Kawahara and Naoto Kitahara, et al.
1377-1384
Original Paper
Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors
Seung Up Kim, Do Young Kim, Jun Yong Park, Sang Hoon Ahn and Hyung Joong Nah, et al.
1385-1396
Original Paper
Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study
Yoichi Arai, Hideyuki Akaza, Takashi Deguchi, Masato Fujisawa and Mikio Hayashi, et al.
1397-1405
Original Paper
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects
Christoph Mundhenke, Marion Tina Weigel, Klarissa Hanja Sturner, Frank Roesel and Ivo Meinhold-Heerlein, et al.